MS Lesions | Symptoms and Diagnosis - Multiple sclerosis lesions
Apr 19, 2022 · MS is defined by the presence of lesions in the nervous system. Learn more about MS lesions and view a picture of what brain lesions look like on an MRI.
ECTRIMS 2024: McDonald criteria changes could speed diagnoses
Sep 25, 2024 · A 2024 version of the McDonald criteria for MS is expected to include new biomarkers to help doctors make accurate diagnoses earlier.
Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
Jan 15, 2025 · Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online.
McDonald criteria | Guidelines for MS diagnosis
Apr 13, 2022 · The McDonald Criteria are a tool that aids in diagnosing MS, using MRI findings as well as clinical and laboratory evaluations.
ACTRIMS 2024: 2 treatments to aid remyelination in MS nearing...
Mar 6, 2024 · Convelo's investigations have produced two new candidates to promote remyelination: CVL-1001 and CVL-2001, which block two proteins.
MS in Men | Symptoms, Life Expectancy, and More
May 19, 2022 · While there are no MS symptoms specific to men, some may be more likely to occur in men. Learn more MS in men, including life expectancy and common experiences.
PIPE-307 shows potential to repair myelin in MS mouse model
Aug 8, 2024 · Treatment with PIPE-307, currently in Phase 2 testing for RRMS, was shown to promote remyelination in a mouse model of multiple sclerosis.
Researchers find sulfuretin molecule may promote myelin repair
Oct 28, 2024 · Researchers found a molecule, sulfuretin, can promote myelin repair, slowing disease progression in MS and some cancers.
Multiple sclerosis prognosis and life expectancy
Feb 13, 2023 · MS is not usually fatal, but it may increase the risk of life-threatening complications. Learn more about MS progression and life expectancy.
Phase 2 trial testing foralumab in nonactive SPMS adds 6 US sites
Dec 6, 2024 · Tiziana's Phase 2 trial testing foralumab for nonactive secondary progressive multiple sclerosis (SPMS) has added six U.S. study sites.